# US 2026/0217761 A1 · Antimicrobial peptide rich in tryptophan and having self-assembly properties, and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0217761 A1
- Document ID: US20260217761A1
- Status: Published application
- Kind: A1
- Application number: 19/142,123
- Filed: 2023-12-20
- Published: 2026-07-30
- Earliest claimed: 2022-12-21
- Applicants: Nanoqure Biotech (Shenzhen) Co., Ltd.
- Inventors: Wenjing ZHAO; Shuli CHOU; Xiangyu MOU; Huating GUO; Shiqing ZHANG
- Web page: https://patentgrep.com/patent/US20260217761A1

## CPC

- C07K 7/06: having 5 to 11 amino acids
- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61P 31/04: Antibacterial agents
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided is a short-chain antimicrobial peptide rich in tryptophan and having self-assembly properties. The short-chain antimicrobial peptide is composed of tryptophan (W) and positively charged amino acids, has self-assembly properties, and can be used as a broad-spectrum antimicrobial peptide against microbial infections, such as co-infections against Pseudomonas aeruginosa and Staphylococcus aureus.

## Claims

### Claim 1

An antimicrobial peptide, wherein the antimicrobial peptide is a short-chain antimicrobial peptide rich in tryptophan and having self-assembly activity.

### Claim 2 (depends on 1)

The antimicrobial peptide according to claim 1,
wherein the antimicrobial peptide is a centrally symmetric 9 amino acid peptide, preferably composed of tryptophan (W) and positively charged amino acids, wherein a number of positively charged amino acids is 3-6.

### Claim 3 (depends on 2)

The antimicrobial peptide according to claim 2, wherein the positively charged amino acid is selected from arginine (R) and lysine (K).

### Claim 4 (depends on 1)

The antimicrobial peptide according to claim 1,
wherein the antimicrobial peptide has a primary symmetric structure with triple tryptophan (WWW) at the center or a tryptophan at the center and double tryptophan (WW) at both ends.

### Claim 5 (depends on 1)

The antimicrobial peptide according to claim 1,
wherein the antimicrobial peptide is a broad-spectrum antimicrobial peptide.

### Claim 6 (depends on 1)

The antimicrobial peptide according to claim 1, which contains a single tryptophan (W) motif, a double tryptophan motif (WW), a triple tryptophan motif (WWW), or a combination thereof, which is evenly separated by positively charged amino acids (+), preferably the antimicrobial peptide contains the double tryptophan motifs (WW) located at both ends.

### Claim 7 (depends on 6)

The antimicrobial peptide according to claim 6,
wherein the antimicrobial peptide is selected from:
wherein “W” represents tryptophan, and “+” represents a positively charged amino acid, such as arginine (R) or lysine (K), preferably; wherein “+” in the same sequence is the same positively charged amino acid.

### Claim 8 (depends on 1)

The antimicrobial peptide according to claim 1, wherein the antimicrobial peptide is selected from any one of SEQ ID NOs: 1 to 4 and a variant thereof containing D-amino acid, preferably SEQ ID NO: 4 (Z4) or Z4-D.

### Claim 9 (depends on 1)

A pharmaceutical composition comprising the antimicrobial peptide according to claim 1.

### Claim 10 (depends on 1)

Use of the antimicrobial peptide according to claim 1 in preparation of a medicament against microbial co-infections.

### Claim 11 (depends on 10)

The use according to claim 10, wherein the microbial co-infections are co-infections of Pseudomonas aeruginosa-Staphylococcus aureus.

### Claim 12 (depends on 2)

The antimicrobial peptide according to claim 2, wherein the amino acid peptide comprises L-amino acids and/or D-amino acids.

### Claim 13 (depends on 2)

The antimicrobial peptide according to claim 2, wherein the number of positively charged amino acids is 4.

### Claim 14 (depends on 2)

The antimicrobial peptide according to claim 2, wherein the number of positively charged amino acids is 6.
